+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Custom Plasmid Production & Manufacturing Market - Global Forecast to 2030- Product Image
Custom Plasmid Production & Manufacturing Market - Global Forecast to 2030- Product Image
New

Custom Plasmid Production & Manufacturing Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 180 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6081732
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The custom plasmid production and manufacturing sector has emerged as a pivotal enabler of modern molecular biology, gene therapy and synthetic biology initiatives. Fueled by advances in cloning vector design, high-efficiency gene synthesis technologies and streamlined service models, this market supports researchers, biotech firms and pharmaceutical developers in tailoring genetic constructs for diverse applications. Organizations increasingly demand plasmids with precise sequence modifications, promoter adjustments and functional enhancements to accelerate R&D timelines, optimize therapeutic payloads and reduce development risk. As novel therapies advance to clinical stages, and environmental and industrial biotechnology applications scale, the ability to deliver bespoke plasmid constructs reliably and cost-effectively becomes a strategic differentiator. Consequently, companies are investing in automated synthesis platforms, robust quality control frameworks and collaborative service agreements to ensure rapid turnaround and regulatory compliance. This introduction outlines the drivers, challenges and innovative trajectories that define the current landscape and set the stage for a deeper analysis of transformational shifts, tariff impacts, segmentation insights, regional dynamics and strategic imperatives.

Transformative Shifts Reshaping Plasmid Manufacturing

Over the last decade, transformative shifts in genomics, automation and digital biology have reshaped custom plasmid manufacturing. First, the maturation of high-throughput DNA synthesis platforms-coupled with advanced cloning technologies-has reduced the time and manual intervention required to generate complex constructs. Parallel advances in viral plasmid systems and large-insert vectors have expanded the range of deliverable genetic payloads, empowering gene therapy and vaccine developers to explore novel modalities. In addition, integration of bioinformatics workflows and cloud-based registries now enables seamless sequence design, real-time tracking and collaborative verification, minimizing errors and accelerating iterative design cycles. Furthermore, growing emphasis on sustainability has driven providers to adopt greener production reagents, energy-efficient processes and waste-minimization protocols. At the same time, regulatory landscapes are tightening around genetically modified organisms, prompting manufacturers to reinforce biosafety and quality-assurance measures. Taken together, these shifts are redefining the competitive criteria: speed and flexibility now rank alongside quality and cost in supplier evaluations, compelling incumbents to innovate across technology, process and service dimensions.

Cumulative Impact of U.S. Tariffs in 2025 on Plasmid Supply Chains

In 2025, the cumulative burden of newly imposed U.S. tariffs on genetic reagents, enzymes and critical lab consumables has reverberated throughout the plasmid supply chain. Manufacturers sourcing polymerases, nucleotides and specialized reagents from international suppliers have encountered elevated input costs, compelling them to recalibrate pricing models and renegotiate supplier agreements. These cost pressures are most acute for providers reliant on imported synthesis modules and high‐fidelity proofreading enzymes. Consequently, some service models have shifted production in-house or toward regions with preferential trade terms, disrupting established logistics flows and extending lead times. On the demand side, end users in academic institutions and small biotech labs have become more price sensitive, opting for template-based or off-the-shelf plasmids when feasible, which has dampened volume growth in fully customized orders. At the same time, larger pharmaceutical and gene therapy developers have absorbed incremental costs to maintain critical supply continuity, leading to strategic partnerships and long-term supply contracts that mitigate exposure to future tariff fluctuations. Overall, the tariff landscape has accelerated market consolidation among top-tier providers and spurred investment in localized production hubs.

Key Insights from Comprehensive Market Segmentation

Detailed segmentation reveals the nuanced drivers and growth pockets across the custom plasmid market. By product type, the industry spans fully custom constructs, pre-made or template plasmids, and standard backbones, with custom constructs further distinguished by large-insert and viral vectors; pre-made plasmids by cDNA clones and genome-editing vectors; and standard backbones by high-copy and low-copy designs. Application segmentation highlights environmental projects-such as bioenergy and bioremediation-alongside core research applications in biotechnology, genetic tracking and molecular biology, and therapeutic deployments in cancer treatment, gene therapy and immunotherapy. In terms of end users, activity is split between academic and research institutions (including university laboratories and private research facilities), biotechnology companies organized into production and R&D groups, and pharmaceutical corporations focused on clinical research and drug development. Service models vary from contract custom production, whether large-scale or small-batch, to fully in-house operations on both large and small scales. On the technology front, cutting-edge cloning, expression and gene synthesis platforms drive differentiation, contrasting advanced and traditional cloning, eukaryotic and prokaryotic expression, and automated versus manual gene synthesis workflows. Finally, customization options encompass vector design choices-bacterial versus viral-functional modifications like promoter engineering and reporter gene integration, and sequence adjustments such as codon optimization and targeted gene deletions. Together, these segmentation insights enable suppliers and end users to identify the most attractive niches, align R&D priorities and allocate resources for maximum impact.

Regional Dynamics Driving Growth and Adoption

Regional trends illustrate distinct growth vectors across the Americas, Europe-Middle East-Africa and Asia-Pacific markets. In the Americas, particularly North America, established infrastructure and robust R&D funding continue to drive demand for high-precision custom plasmids in gene therapy and oncology research. Latin American researchers, meanwhile, are increasingly adopting template plasmid libraries to expedite early-stage investigations. In EMEA, leading academic consortia and governmental biotech initiatives in Western Europe foster collaboration on synthetic biology and environmental applications, while regulatory convergence around biosafety standards promotes market entry for specialized service providers. The Middle East market, still nascent, is benefiting from targeted investments in biomedical clusters. Across Asia-Pacific, rapid expansion in biopharma ecosystems-driven by China’s large-scale gene therapy programs, India’s affordable technology platforms and Australia’s emphasis on agricultural biotechnology-spurs demand for both cost-effective standard plasmids and complex custom constructs. Providers that optimize logistics, localize production and adapt service offerings to regional regulatory and budgetary conditions will secure a competitive edge in these diverse territories.

Competitive Landscape and Key Player Strategies

The competitive landscape features an array of specialized and full-service providers, each leveraging unique assets to capture market share. Addgene’s repository model and open-access ethos have positioned it as a go-to source for standard and pre-made plasmids, while Aldevron, LLC excels in large-scale GMP-compliant custom production for clinical and commercial therapeutics. Bio Basic Inc. and Enzo Life Sciences, Inc. maintain broad reagent portfolios that integrate plasmid services with complementary assay kits, and Eurofins Genomics differentiates through global sequencing and quality assurance capabilities. GeneCopoeia, Inc. and GenScript Biotech Corporation offer end-to-end gene synthesis and vector design platforms that streamline client workflows, whereas Creative Biogene and PlasmidFactory GmbH & Co. KG focus on specialized viral and large-insert constructs for advanced gene therapy applications. Ginkgo Bioworks, Inc. applies its synthetic biology foundry model to automate high-throughput plasmid assembly, while Twist Bioscience Corporation’s silicon-based synthesis technology accelerates production at scale. Life Technologies Corporation, as part of Thermo Fisher Scientific, and OriGene Technologies, Inc. leverage expansive sales networks and integrated service offerings to address multi-dimensional customer needs. Finally, Vigene Biosciences, Inc. stands out for its proprietary viral vector platforms, delivering custom AAV and lentiviral solutions to facilitate in vivo expression studies. Collectively, these firms underscore the importance of technology leadership, geographic footprint and service versatility in defining the next wave of innovation.

Actionable Recommendations for Industry Leaders

To thrive amidst evolving technologies and shifting trade policies, industry participants must adopt a proactive and customer-centric posture. First, investing in modular automation systems and advanced bioinformatics will shorten design-to-delivery timelines and reduce per-construct costs. Second, establishing regional production hubs or strategic partnerships in tariff-friendly jurisdictions will insulate supply chains from geopolitical volatility. Third, expanding value-added services-such as vector consultation, regulatory support and end-to-end assay integration-will deepen customer relationships and create upsell opportunities. Fourth, differentiating through sustainability initiatives, including reduced-waste reagent kits and energy-efficient workflows, will resonate with environmentally conscious organizations and enhance brand reputation. Fifth, forging collaborative research alliances with academic consortia and biotech accelerators can drive early access to emerging applications and novel therapeutic targets. By pursuing these recommendations, leaders can unlock operational efficiencies, diversify revenue streams and strengthen resilience against external shocks.

Conclusion: Navigating Complexity to Drive Innovation

In summary, the custom plasmid production market stands at the intersection of technological innovation, regulatory complexity and global trade dynamics. Key drivers include demand for precise genetic constructs, the proliferation of gene-based therapies and breakthroughs in automated synthesis and expression technologies. At the same time, U.S. tariffs and shifting regional policies have prompted supply chain realignments, creating opportunities for localized service models and strategic partnerships. Through rigorous segmentation analysis, it becomes clear that providers can optimize their value propositions by aligning product, application, end-user and service capabilities with specific market niches. Competitive success will depend on agility in technology deployment, geographic diversification and the expansion of customer-focused, integrated offerings. As stakeholders navigate this dynamic environment, the capacity to innovate, collaborate and adapt will determine who leads the next wave of breakthroughs.

Market Segmentation & Coverage

This research report categorizes the Custom Plasmid Production & Manufacturing Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Custom Plasmids
    • Large-Inserts Plasmids
    • Viral Plasmids
  • Pre-Made/Template Plasmids
    • cDNA Clones
    • Genome Editing Plasmids
  • Standard Plasmids
    • High-Copy Plasmids
    • Low-Copy Plasmids
  • Environmental Applications
    • Bioenergy
    • Bioremediation Applications
  • Research Applications
    • Biotechnology
    • Genetic Tracking
    • Molecular Biology
  • Therapeutic Applications
    • Cancer Treatment
    • Gene Therapy
    • Immunotherapy
  • Academic & Research Institutions
    • Private Research Labs
    • University Laboratories
  • Biotechnology Firms
    • Production Departments
    • R&D Departments
  • Pharmaceutical Companies
    • Clinical Research
    • Drug Development
  • Contract Custom Production
    • Large-Scale Production
    • Small-Scale Production
  • In-House Custom Production
    • Large In-House Operations
    • Small In-House Operations
  • Cloning Technologies
    • Advanced Cloning
    • Traditional Cloning
  • Expression Technologies
    • Eukaryotic Expression
    • Prokaryotic Expression
  • Gene Synthesis Technologies
    • Automated Synthesis
    • Manual Synthesis
  • Cloning Vector Designs
    • Bacterial Vectors
    • Viral Vectors
  • Functional Modifications
    • Promoter Modifications
    • Reporter Gene Inclusion
  • Sequence Modifications
    • Codon Optimization
    • Gene Deletions

This research report categorizes the Custom Plasmid Production & Manufacturing Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Custom Plasmid Production & Manufacturing Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Addgene
  • Aldevron, LLC
  • Bio Basic Inc.
  • Biocat GmbH
  • Creative Biogene
  • Enzo Life Sciences, Inc.
  • Eurofins Genomics
  • GeneCopoeia, Inc.
  • GenScript Biotech Corporation
  • Ginkgo Bioworks, Inc.
  • Life Technologies Corporation (part of Thermo Fisher Scientific)
  • OriGene Technologies, Inc.
  • PlasmidFactory GmbH & Co. KG
  • Twist Bioscience Corporation
  • Vigene Biosciences, Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Custom Plasmid Production & Manufacturing Market, by Product Type
8.1. Introduction
8.2. Custom Plasmids
8.2.1. Large-Inserts Plasmids
8.2.2. Viral Plasmids
8.3. Pre-Made/Template Plasmids
8.3.1. cDNA Clones
8.3.2. Genome Editing Plasmids
8.4. Standard Plasmids
8.4.1. High-Copy Plasmids
8.4.2. Low-Copy Plasmids
9. Custom Plasmid Production & Manufacturing Market, by Application
9.1. Introduction
9.2. Environmental Applications
9.2.1. Bioenergy
9.2.2. Bioremediation Applications
9.3. Research Applications
9.3.1. Biotechnology
9.3.2. Genetic Tracking
9.3.3. Molecular Biology
9.4. Therapeutic Applications
9.4.1. Cancer Treatment
9.4.2. Gene Therapy
9.4.3. Immunotherapy
10. Custom Plasmid Production & Manufacturing Market, by End User
10.1. Introduction
10.2. Academic & Research Institutions
10.2.1. Private Research Labs
10.2.2. University Laboratories
10.3. Biotechnology Firms
10.3.1. Production Departments
10.3.2. R&D Departments
10.4. Pharmaceutical Companies
10.4.1. Clinical Research
10.4.2. Drug Development
11. Custom Plasmid Production & Manufacturing Market, by Service Models
11.1. Introduction
11.2. Contract Custom Production
11.2.1. Large-Scale Production
11.2.2. Small-Scale Production
11.3. In-House Custom Production
11.3.1. Large In-House Operations
11.3.2. Small In-House Operations
12. Custom Plasmid Production & Manufacturing Market, by Technology
12.1. Introduction
12.2. Cloning Technologies
12.2.1. Advanced Cloning
12.2.2. Traditional Cloning
12.3. Expression Technologies
12.3.1. Eukaryotic Expression
12.3.2. Prokaryotic Expression
12.4. Gene Synthesis Technologies
12.4.1. Automated Synthesis
12.4.2. Manual Synthesis
13. Custom Plasmid Production & Manufacturing Market, by Customization Options
13.1. Introduction
13.2. Cloning Vector Designs
13.2.1. Bacterial Vectors
13.2.2. Viral Vectors
13.3. Functional Modifications
13.3.1. Promoter Modifications
13.3.2. Reporter Gene Inclusion
13.4. Sequence Modifications
13.4.1. Codon Optimization
13.4.2. Gene Deletions
14. Americas Custom Plasmid Production & Manufacturing Market
14.1. Introduction
14.2. Argentina
14.3. Brazil
14.4. Canada
14.5. Mexico
14.6. United States
15. Asia-Pacific Custom Plasmid Production & Manufacturing Market
15.1. Introduction
15.2. Australia
15.3. China
15.4. India
15.5. Indonesia
15.6. Japan
15.7. Malaysia
15.8. Philippines
15.9. Singapore
15.10. South Korea
15.11. Taiwan
15.12. Thailand
15.13. Vietnam
16. Europe, Middle East & Africa Custom Plasmid Production & Manufacturing Market
16.1. Introduction
16.2. Denmark
16.3. Egypt
16.4. Finland
16.5. France
16.6. Germany
16.7. Israel
16.8. Italy
16.9. Netherlands
16.10. Nigeria
16.11. Norway
16.12. Poland
16.13. Qatar
16.14. Russia
16.15. Saudi Arabia
16.16. South Africa
16.17. Spain
16.18. Sweden
16.19. Switzerland
16.20. Turkey
16.21. United Arab Emirates
16.22. United Kingdom
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Addgene
17.3.2. Aldevron, LLC
17.3.3. Bio Basic Inc.
17.3.4. Biocat GmbH
17.3.5. Creative Biogene
17.3.6. Enzo Life Sciences, Inc.
17.3.7. Eurofins Genomics
17.3.8. GeneCopoeia, Inc.
17.3.9. GenScript Biotech Corporation
17.3.10. Ginkgo Bioworks, Inc.
17.3.11. Life Technologies Corporation (part of Thermo Fisher Scientific)
17.3.12. OriGene Technologies, Inc.
17.3.13. PlasmidFactory GmbH & Co. KG
17.3.14. Twist Bioscience Corporation
17.3.15. Vigene Biosciences, Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET MULTI-CURRENCY
FIGURE 2. CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET MULTI-LANGUAGE
FIGURE 3. CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY SERVICE MODELS, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY SERVICE MODELS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CUSTOMIZATION OPTIONS, 2024 VS 2030 (%)
FIGURE 18. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CUSTOMIZATION OPTIONS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CUSTOM PLASMIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY LARGE-INSERTS PLASMIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY VIRAL PLASMIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CUSTOM PLASMIDS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY PRE-MADE/TEMPLATE PLASMIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CDNA CLONES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY GENOME EDITING PLASMIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY PRE-MADE/TEMPLATE PLASMIDS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY STANDARD PLASMIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY HIGH-COPY PLASMIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY LOW-COPY PLASMIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY STANDARD PLASMIDS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY ENVIRONMENTAL APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY BIOENERGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY BIOREMEDIATION APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY ENVIRONMENTAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY RESEARCH APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY BIOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY GENETIC TRACKING, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY MOLECULAR BIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CANCER TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY PRIVATE RESEARCH LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY UNIVERSITY LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY PRODUCTION DEPARTMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY R&D DEPARTMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY BIOTECHNOLOGY FIRMS, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY SERVICE MODELS, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CONTRACT CUSTOM PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY LARGE-SCALE PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY SMALL-SCALE PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CONTRACT CUSTOM PRODUCTION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY IN-HOUSE CUSTOM PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY LARGE IN-HOUSE OPERATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY SMALL IN-HOUSE OPERATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY IN-HOUSE CUSTOM PRODUCTION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CLONING TECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY ADVANCED CLONING, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY TRADITIONAL CLONING, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CLONING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY EXPRESSION TECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY EUKARYOTIC EXPRESSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY PROKARYOTIC EXPRESSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY EXPRESSION TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY GENE SYNTHESIS TECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY AUTOMATED SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY MANUAL SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY GENE SYNTHESIS TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CUSTOMIZATION OPTIONS, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CLONING VECTOR DESIGNS, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY BACTERIAL VECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY VIRAL VECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CLONING VECTOR DESIGNS, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY FUNCTIONAL MODIFICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY PROMOTER MODIFICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY REPORTER GENE INCLUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY FUNCTIONAL MODIFICATIONS, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY SEQUENCE MODIFICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CODON OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY GENE DELETIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY SEQUENCE MODIFICATIONS, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CUSTOM PLASMIDS, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY PRE-MADE/TEMPLATE PLASMIDS, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY STANDARD PLASMIDS, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY ENVIRONMENTAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY BIOTECHNOLOGY FIRMS, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY SERVICE MODELS, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CONTRACT CUSTOM PRODUCTION, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY IN-HOUSE CUSTOM PRODUCTION, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CLONING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY EXPRESSION TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY GENE SYNTHESIS TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CUSTOMIZATION OPTIONS, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CLONING VECTOR DESIGNS, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY FUNCTIONAL MODIFICATIONS, 2018-2030 (USD MILLION)
TABLE 104. AMERICAS CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY SEQUENCE MODIFICATIONS, 2018-2030 (USD MILLION)
TABLE 105. AMERICAS CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CUSTOM PLASMIDS, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY PRE-MADE/TEMPLATE PLASMIDS, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY STANDARD PLASMIDS, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY ENVIRONMENTAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY BIOTECHNOLOGY FIRMS, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY SERVICE MODELS, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CONTRACT CUSTOM PRODUCTION, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY IN-HOUSE CUSTOM PRODUCTION, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CLONING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY EXPRESSION TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY GENE SYNTHESIS TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CUSTOMIZATION OPTIONS, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CLONING VECTOR DESIGNS, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY FUNCTIONAL MODIFICATIONS, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY SEQUENCE MODIFICATIONS, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CUSTOM PLASMIDS, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY PRE-MADE/TEMPLATE PLASMIDS, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY STANDARD PLASMIDS, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY ENVIRONMENTAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY BIOTECHNOLOGY FIRMS, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY SERVICE MODELS, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CONTRACT CUSTOM PRODUCTION, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY IN-HOUSE CUSTOM PRODUCTION, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CLONING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY EXPRESSION TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY GENE SYNTHESIS TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CUSTOMIZATION OPTIONS, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CLONING VECTOR DESIGNS, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY FUNCTIONAL MODIFICATIONS, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY SEQUENCE MODIFICATIONS, 2018-2030 (USD MILLION)
TABLE 152. CANADA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 153. CANADA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CUSTOM PLASMIDS, 2018-2030 (USD MILLION)
TABLE 154. CANADA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY PRE-MADE/TEMPLATE PLASMIDS, 2018-2030 (USD MILLION)
TABLE 155. CANADA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY STANDARD PLASMIDS, 2018-2030 (USD MILLION)
TABLE 156. CANADA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. CANADA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY ENVIRONMENTAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 158. CANADA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 159. CANADA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 160. CANADA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 161. CANADA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 162. CANADA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY BIOTECHNOLOGY FIRMS, 2018-2030 (USD MILLION)
TABLE 163. CANADA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 164. CANADA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY SERVICE MODELS, 2018-2030 (USD MILLION)
TABLE 165. CANADA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CONTRACT CUSTOM PRODUCTION, 2018-2030 (USD MILLION)
TABLE 166. CANADA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY IN-HOUSE CUSTOM PRODUCTION, 2018-2030 (USD MILLION)
TABLE 167. CANADA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 168. CANADA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CLONING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 169. CANADA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY EXPRESSION TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 170. CANADA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY GENE SYNTHESIS TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 171. CANADA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CUSTOMIZATION OPTIONS, 2018-2030 (USD MILLION)
TABLE 172. CANADA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CLONING VECTOR DESIGNS, 2018-2030 (USD MILLION)
TABLE 173. CANADA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY FUNCTIONAL MODIFICATIONS, 2018-2030 (USD MILLION)
TABLE 174. CANADA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY SEQUENCE MODIFICATIONS, 2018-2030 (USD MILLION)
TABLE 175. MEXICO CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 176. MEXICO CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CUSTOM PLASMIDS, 2018-2030 (USD MILLION)
TABLE 177. MEXICO CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY PRE-MADE/TEMPLATE PLASMIDS, 2018-2030 (USD MILLION)
TABLE 178. MEXICO CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY STANDARD PLASMIDS, 2018-2030 (USD MILLION)
TABLE 179. MEXICO CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. MEXICO CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY ENVIRONMENTAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 181. MEXICO CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 182. MEXICO CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 183. MEXICO CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. MEXICO CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 185. MEXICO CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY BIOTECHNOLOGY FIRMS, 2018-2030 (USD MILLION)
TABLE 186. MEXICO CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 187. MEXICO CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY SERVICE MODELS, 2018-2030 (USD MILLION)
TABLE 188. MEXICO CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CONTRACT CUSTOM PRODUCTION, 2018-2030 (USD MILLION)
TABLE 189. MEXICO CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY IN-HOUSE CUSTOM PRODUCTION, 2018-2030 (USD MILLION)
TABLE 190. MEXICO CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 191. MEXICO CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CLONING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 192. MEXICO CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY EXPRESSION TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 193. MEXICO CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY GENE SYNTHESIS TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 194. MEXICO CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CUSTOMIZATION OPTIONS, 2018-2030 (USD MILLION)
TABLE 195. MEXICO CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CLONING VECTOR DESIGNS, 2018-2030 (USD MILLION)
TABLE 196. MEXICO CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY FUNCTIONAL MODIFICATIONS, 2018-2030 (USD MILLION)
TABLE 197. MEXICO CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY SEQUENCE MODIFICATIONS, 2018-2030 (USD MILLION)
TABLE 198. UNITED STATES CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 199. UNITED STATES CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CUSTOM PLASMIDS, 2018-2030 (USD MILLION)
TABLE 200. UNITED STATES CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY PRE-MADE/TEMPLATE PLASMIDS, 2018-2030 (USD MILLION)
TABLE 201. UNITED STATES CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY STANDARD PLASMIDS, 2018-2030 (USD MILLION)
TABLE 202. UNITED STATES CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. UNITED STATES CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY ENVIRONMENTAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 204. UNITED STATES CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 205. UNITED STATES CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 206. UNITED STATES CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. UNITED STATES CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 208. UNITED STATES CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY BIOTECHNOLOGY FIRMS, 2018-2030 (USD MILLION)
TABLE 209. UNITED STATES CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 210. UNITED STATES CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY SERVICE MODELS, 2018-2030 (USD MILLION)
TABLE 211. UNITED STATES CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CONTRACT CUSTOM PRODUCTION, 2018-2030 (USD MILLION)
TABLE 212. UNITED STATES CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY IN-HOUSE CUSTOM PRODUCTION, 2018-2030 (USD MILLION)
TABLE 213. UNITED STATES CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 214. UNITED STATES CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CLONING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 215. UNITED STATES CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY EXPRESSION TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 216. UNITED STATES CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY GENE SYNTHESIS TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 217. UNITED STATES CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CUSTOMIZATION OPTIONS, 2018-2030 (USD MILLION)
TABLE 218. UNITED STATES CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CLONING VECTOR DESIGNS, 2018-2030 (USD MILLION)
TABLE 219. UNITED STATES CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY FUNCTIONAL MODIFICATIONS, 2018-2030 (USD MILLION)
TABLE 220. UNITED STATES CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY SEQUENCE MODIFICATIONS, 2018-2030 (USD MILLION)
TABLE 221. UNITED STATES CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 222. ASIA-PACIFIC CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 223. ASIA-PACIFIC CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CUSTOM PLASMIDS, 2018-2030 (USD MILLION)
TABLE 224. ASIA-PACIFIC CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY PRE-MADE/TEMPLATE PLASMIDS, 2018-2030 (USD MILLION)
TABLE 225. ASIA-PACIFIC CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY STANDARD PLASMIDS, 2018-2030 (USD MILLION)
TABLE 226. ASIA-PACIFIC CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 227. ASIA-PACIFIC CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY ENVIRONMENTAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 228. ASIA-PACIFIC CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 229. ASIA-PACIFIC CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 230. ASIA-PACIFIC CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 231. ASIA-PACIFIC CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 232. ASIA-PACIFIC CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY BIOTECHNOLOGY FIRMS, 2018-2030 (USD MILLION)
TABLE 233. ASIA-PACIFIC CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 234. ASIA-PACIFIC CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY SERVICE MODELS, 2018-2030 (USD MILLION)
TABLE 235. ASIA-PACIFIC CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CONTRACT CUSTOM PRODUCTION, 2018-2030 (USD MILLION)
TABLE 236. ASIA-PACIFIC CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY IN-HOUSE CUSTOM PRODUCTION, 2018-2030 (USD MILLION)
TABLE 237. ASIA-PACIFIC CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 238. ASIA-PACIFIC CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CLONING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 239. ASIA-PACIFIC CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY EXPRESSION TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 240. ASIA-PACIFIC CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY GENE SYNTHESIS TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 241. ASIA-PACIFIC CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CUSTOMIZATION OPTIONS, 2018-2030 (USD MILLION)
TABLE 242. ASIA-PACIFIC CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CLONING VECTOR DESIGNS, 2018-2030 (USD MILLION)
TABLE 243. ASIA-PACIFIC CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY FUNCTIONAL MODIFICATIONS, 2018-2030 (USD MILLION)
TABLE 244. ASIA-PACIFIC CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY SEQUENCE MODIFICATIONS, 2018-2030 (USD MILLION)
TABLE 245. ASIA-PACIFIC CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 246. AUSTRALIA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 247. AUSTRALIA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CUSTOM PLASMIDS, 2018-2030 (USD MILLION)
TABLE 248. AUSTRALIA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY PRE-MADE/TEMPLATE PLASMIDS, 2018-2030 (USD MILLION)
TABLE 249. AUSTRALIA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY STANDARD PLASMIDS, 2018-2030 (USD MILLION)
TABLE 250. AUSTRALIA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 251. AUSTRALIA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY ENVIRONMENTAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 252. AUSTRALIA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 253. AUSTRALIA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 254. AUSTRALIA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 255. AUSTRALIA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 256. AUSTRALIA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY BIOTECHNOLOGY FIRMS, 2018-2030 (USD MILLION)
TABLE 257. AUSTRALIA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 258. AUSTRALIA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY SERVICE MODELS, 2018-2030 (USD MILLION)
TABLE 259. AUSTRALIA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CONTRACT CUSTOM PRODUCTION, 2018-2030 (USD MILLION)
TABLE 260. AUSTRALIA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY IN-HOUSE CUSTOM PRODUCTION, 2018-2030 (USD MILLION)
TABLE 261. AUSTRALIA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 262. AUSTRALIA CUSTOM PLASMID PRODUCTION & MANUFACTURING MARKET SIZE, BY CLONING TECHNOLOGIES, 2018-

Companies Mentioned

  • Addgene
  • Aldevron, LLC
  • Bio Basic Inc.
  • Biocat GmbH
  • Creative Biogene
  • Enzo Life Sciences, Inc.
  • Eurofins Genomics
  • GeneCopoeia, Inc.
  • GenScript Biotech Corporation
  • Ginkgo Bioworks, Inc.
  • Life Technologies Corporation (part of Thermo Fisher Scientific)
  • OriGene Technologies, Inc.
  • PlasmidFactory GmbH & Co. KG
  • Twist Bioscience Corporation
  • Vigene Biosciences, Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Research Grade Plasmid DNA Manufacturing Market - Global Forecast to 2030 - Product Image

Research Grade Plasmid DNA Manufacturing Market - Global Forecast to 2030

  • Report
  • 182 Pages
  • Global, United States Global, United States
From
Plasmid Purification - Global Strategic Business Report - Product Image

Plasmid Purification - Global Strategic Business Report

  • Report
  • 78 Pages
  • Global
From
Plasmid DNA Contract Manufacturing - Global Strategic Business Report - Product Image

Plasmid DNA Contract Manufacturing - Global Strategic Business Report

  • Report
  • 66 Pages
  • Global
From
U.S. mRNA Synthesis Raw Materials Market Size, Share & Trends Analysis Report, Type (Capping Agents, Nucleotides, Plasmid DNA), Application (Vaccine, Therapeutics), End-use, and Segment Forecasts, 2024-2030 - Product Image

U.S. mRNA Synthesis Raw Materials Market Size, Share & Trends Analysis Report, Type (Capping Agents, Nucleotides, Plasmid DNA), Application (Vaccine, Therapeutics), End-use, and Segment Forecasts, 2024-2030

  • Report
  • 90 Pages
  • United States
From
Plasmid Purification Market Size, Share & Trends Analysis Report By Product & Service (Kits & Reagents, Instruments), By Grade (Molecular Grade, Transfection Grade), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Plasmid Purification Market Size, Share & Trends Analysis Report By Product & Service (Kits & Reagents, Instruments), By Grade (Molecular Grade, Transfection Grade), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 120 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.